Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunoglobulin a Nephropathy”

388 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 388 results

Very early researchLooking for participantsNCT06792799
What this trial is testing

Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErthematosusMulti-Drug Resistant Nephrotic Syndrome+1 more
The Children's Hospital of Zhejiang University School of Medicine 36
Not applicableLooking for participantsNCT05791162
What this trial is testing

Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGA
Centre Hospitalier Universitaire de Besancon 75
Not applicableStudy completedNCT06460987
What this trial is testing

Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy

Who this might be right for
FinerenoneIgA NephropathyProteinuria+1 more
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 245
Early research (Phase 1)Looking for participantsNCT07123519
What this trial is testing

A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Sjogren's Syndrome (SS)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Very early researchLooking for participantsNCT07389499
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases

Who this might be right for
IgA Nephropathy (IgAN)Membranous NephropathyANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN)+2 more
Grit Biotechnology 30
Not applicableEnded earlyNCT00586716
What this trial is testing

Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients

Who this might be right for
End Stage Renal Disease
Loma Linda University 22
Testing effectiveness (Phase 2)Study completedNCT01337752
What this trial is testing

Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency

Who this might be right for
Multiple MyelomaRenal Insufficiency
Novartis Pharmaceuticals 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT05239533
What this trial is testing

Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaKidney CancerAdvanced Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center 9
Very early researchWithdrawnNCT06926985
What this trial is testing

An Exploratory Clinical Study of Anti-CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in the Treatment of IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
Jieyang People's Hospital
Testing effectiveness (Phase 2)Study completedNCT01058538
What this trial is testing

A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumours
Philogen S.p.A. 33
Large-scale testing (Phase 3)Study completedNCT03920072
What this trial is testing

Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd 35
Post-approval studies (Phase 4)UnknownNCT02981212
What this trial is testing

Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy

Who this might be right for
IgA Nephropathy
Yonsei University 100
Early research (Phase 1)Looking for participantsNCT06147037
What this trial is testing

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more
AstraZeneca 70
Not applicableLooking for participantsNCT05434325
What this trial is testing

TESTING -ON Post-Trial ObservatioNal Cohort Study

Who this might be right for
IgA NephropathyESRDGlomerulonephritis+1 more
The George Institute 366
Testing effectiveness (Phase 2)Looking for participantsNCT06797518
What this trial is testing

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

Who this might be right for
Glomerulonephritis, IGAImmunoglobulin A Nephropathy
Novartis Pharmaceuticals 20
Not applicableLooking for participantsNCT04858724
What this trial is testing

The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)

Who this might be right for
IgA Nephropathy
Ruijin Hospital 2,000
Large-scale testing (Phase 3)Study completedNCT02282930
What this trial is testing

Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

Who this might be right for
Progressive IgA NephropathyProteinuria
Mayo Clinic 20
Testing effectiveness (Phase 2)Study completedNCT03453619
What this trial is testing

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

Who this might be right for
IgA NephropathyLupus NephritisMembranous Nephropathy+2 more
Apellis Pharmaceuticals, Inc. 21
Not applicableLooking for participantsNCT05106387
What this trial is testing

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

Who this might be right for
Chronic Kidney Disease (CKD)
Regeneron Pharmaceuticals 20
Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Load More Results